Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis

Arthritis Research and Therapy

Volumn 15, Issue 5, 2013, Pages

  Nistala, Kiran ^a   Varsani, Hemlata ^a   Wittkowski, Helmut ^c   Vogl, Thomas ^b   Krol, Petra ^d   Shah, Vanita ^a   Mamchaoui, Kamel ^e   Brogan, Paul A ^a   Roth, Johannes ^b   Wedderburn, Lucy R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d CHARLES UNIVERSITY   (Czech Republic)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID RELATED PROTEIN 14; MYELOID RELATED PROTEIN 8; PROTEIN; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCC11 PROTEIN, HUMAN; AUTACOID; CALGRANULIN B; CCL2 PROTEIN, HUMAN; CD68 ANTIGEN, HUMAN; CYTOKINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMAN; HUMAN CELL CULTURE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; JUVENILE DERMATOMYOSITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE EXERCISE; MUSCLE STRENGTH; MUSCLE TISSUE; MYOBLAST; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; STIMULATION; SUPERNATANT; ADOLESCENT; AMYOPATHIC DERMATOMYOSITIS; BIOPSY; BLOOD; CELL LINE; CYTOLOGY; DERMATOMYOSITIS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; METABOLISM; MUSCLE; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; CALGRANULIN B; CELL LINE; CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; CYTOKINES; DERMATOMYOSITIS; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MACROPHAGES; MALE; MICROSCOPY, FLUORESCENCE; MUSCLE STRENGTH; MUSCLES; MYOBLASTS, SKELETAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84884404667     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4311     Document Type: Article

References (48)

1. Wedderburn LR, Rider LG. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Pract Res Clin Rheumatol 2009, 23:665-678. 10.1016/j.berh.2009.07.007, 2774891, 19853831.
2. Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 2008, 47:324-328.
3. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011, 34:108-121. 10.1016/j.immuni.2010.12.012, 3046815, 21215658.
4. Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum 2009, 60:3436-3446. 10.1002/art.24936, 19877033.
5. Li CK, Varsani H, Holton JL, Gao B, Woo P, Wedderburn LR. MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 2004, 31:605-609.
6. Bartoccioni E, Gallucci S, Scuderi F, Ricci E, Servidei S, Broccolini A, Tonali P. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 1994, 95:166-172. 1534629, 7507012.
7. Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, Chang J, Dwivedi S, Mitsak M, Chen YW, Plotz P, Rosen A, Hoffman E, Raben N. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 2005, 52:1824-1835. 10.1002/art.21103, 15934115.
8. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 2000, 97:9209-9214. 10.1073/pnas.97.16.9209, 16847, 10922072.
9. Li CK, Knopp P, Moncrieffe H, Singh B, Shah S, Nagaraju K, Varsani H, Gao B, Wedderburn LR. Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis. Am J Pathol 2009, 175:1030-1040. 10.2353/ajpath.2009.090196, 2731122, 19700752.
10. Seeliger S, Vogl T, Engels IH, Schroder JM, Sorg C, Sunderkotter C, Roth J. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathol 2003, 163:947-956. 10.1016/S0002-9440(10)63454-2, 1868263, 12937135.
11. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, Nacken W, Klenner L, Kuhn A, Foell D, Sorokin L, Luger TA, Roth J, Beissert S. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 2010, 16:713-717. 10.1038/nm.2150, 20473308.
12. Hirono K, Foell D, Xing Y, Miyagawa-Tomita S, Ye F, Ahlmann M, Vogl T, Futatani T, Rui C, Yu X, Watanabe K, Wanatabe S, Tsubata S, Uese K, Hashimoto I, Ichida F, Nakazawa M, Roth J, Miyawaki T. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease. J Am Coll Cardiol 2006, 48:1257-1264. 10.1016/j.jacc.2006.02.077, 16979015.
13. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43:628-637. 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X, 10728757.
14. Pilkington CA, Wedderburn LR. Paediatric idiopathic inflammatory muscle disease: recognition and management. Drugs 2005, 65:1355-1365. 10.2165/00003495-200565100-00004, 15977968.
15. Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, Wedderburn LR. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology (Oxford) 2011, 50:137-145.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403-407. 10.1056/NEJM197502202920807, 1089199.
17. Varsani H, Newton KR, Li CK, Harding B, Holton JL, Wedderburn LR. Quantification of normal range of inflammatory changes in morphologically normal pediatric muscle. Muscle Nerve 2008, 37:259-261. 10.1002/mus.20898, 17847070.
18. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, Hicks JE, Levinson JE, Mier R, Pachman LM, Passo MH, Perez MD, Reed AM, Schikler KN, Smith M, Zemel LS, Rider LG. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999, 42:2213-2219. 10.1002/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8, 10524696.
19. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003, 30:603-617.
20. de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005, 300:124-135. 10.1016/j.jim.2005.03.009, 15896801.
21. Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith A, Harding B, Hoogendijk J, Lundberg IE, Marie S, Minetti C, Nennesmo I, Rushing EJ, Sewry C, Charman SC, Pilkington CA, Holton JL, UK Juvenile Dermatomyositis Research Group International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007, 57:1192-1201. 10.1002/art.23012, 17907237, UK Juvenile Dermatomyositis Research Group.
22. Zwadlo G, Schlegel R, Sorg C. A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 1986, 137:512-518.
23. Roth J, Goebeler M, Erpenstein U, Sorg C. Differential regulation of the macrophage-specific surface antigen RM3/1 by cyclosporine, azathioprine, and dexamethasone. Transplantation 1994, 57:127-133. 10.1097/00007890-199401000-00020, 8291098.
24. Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 2007, 6:515-523. 10.1111/j.1474-9726.2007.00306.x, 17559502.
25. Vogl T, Leukert N, Barczyk K, Strupat K, Roth J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim Biophys Acta 2006, 1763:1298-1306. 10.1016/j.bbamcr.2006.08.028, 17050004.
26. Price BD, Mannheim-Rodman LA, Calderwood SK. Brefeldin A, thapsigargin, and AIF4- stimulate the accumulation of GRP78 mRNA in a cycloheximide dependent manner, whilst induction by hypoxia is independent of protein synthesis. J Cell Physiol 1992, 152:545-552. 10.1002/jcp.1041520314, 1506413.
27. Liprandi A, Bartoli C, Figarella-Branger D, Pellissier JF, Lepidi H. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol 1999, 97:642-648. 10.1007/s004010051041, 10378384.
28. Komohara Y, Hirahara J, Horikawa T, Kawamura K, Kiyota E, Sakashita N, Araki N, Takeya M. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 2006, 54:763-771. 10.1369/jhc.5A6871.2006, 16517975.
29. Przybyla B, Gurley C, Harvey JF, Bearden E, Kortebein P, Evans WJ, Sullivan DH, Peterson CA, Dennis RA. Aging alters macrophage properties in human skeletal muscle both at rest and in response to acute resistance exercise. Exp Gerontol 2006, 41:320-327. 10.1016/j.exger.2005.12.007, 16457979.
30. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998, 113:407-414. 10.1046/j.1365-2249.1998.00664.x, 1905062, 9737670.
31. Vattemi G, Engel WK, McFerrin J, Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 2004, 164:1-7. 10.1016/S0002-9440(10)63089-1, 1602240, 14695312.
32. Hirota M, Kitagaki M, Itagaki H, Aiba S. Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress. J Toxicol Sci 2006, 31:149-156. 10.2131/jts.31.149, 16772704.
33. Martinon F, Chen X, Lee AH, Glimcher LH. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 2010, 11:411-418. 10.1038/ni.1857, 3113706, 20351694.
34. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461. 10.1126/science.1103160, 15486293.
35. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007, 13:1042-1049. 10.1038/nm1638, 17767165.
36. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000, 47:506-513. 10.1136/gut.47.4.506, 1728060, 10986210.
37. Foell D, Wulffraat N, Wedderburn LR, Wittkowski H, Frosch M, Gerss J, Stanevicha V, Mihaylova D, Ferriani V, Tsakalidou FK, Foeldvari I, Cuttica R, Gonzalez B, Ravelli A, Khubchandani R, Oliveira S, Armbrust W, Garay S, Vojinovic J, Norambuena X, Gamir ML, García-Consuegra J, Lepore L, Susic G, Corona F, Dolezalova P, Pistorio A, Martini A, Ruperto N, Roth J, Paediatric Rheumatology International Trials Organization (PRINTO) Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010, 303:1266-1273. 10.1001/jama.2010.375, 20371785, Paediatric Rheumatology International Trials Organization (PRINTO).
38. Salajegheh M, Kong SW, Pinkus JL, Walsh RJ, Liao A, Nazareno R, Amato AA, Krastins B, Morehouse C, Higgs BW, Jallal B, Yao Y, Sarracino DA, Parker KC, Greenberg SA. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 2010, 67:53-63. 10.1002/ana.21805, 2875060, 20186858.
39. Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, Bremer EG, Krasnoselska-Riz I, Kumar A, Pachman LM. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 2002, 168:4154-4163.
40. Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, Hein MS, Crowson CS, Ernste F, Gillespie EB. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum 2012, 64:4078-4086. 10.1002/art.34659, 22886447.
41. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25:383-392. 10.1016/j.immuni.2006.08.010, 16979570.
42. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994, 91:2752-2756. 10.1073/pnas.91.7.2752, 43448, 8146186.
43. De Paepe B, De Bleecker JL. Beta-chemokine receptor expression in idiopathic inflammatory myopathies. Muscle Nerve 2005, 31:621-627. 10.1002/mus.20294, 15772970.
44. Delogu A, Schebesta A, Sun Q, Aschenbrenner K, Perlot T, Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 2006, 24:269-281. 10.1016/j.immuni.2006.01.012, 16546096.
45. Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis 2011, 204:1026-1030. 10.1093/infdis/jir470, 21881117.
46. Tournadre A, Lenief V, Eljaafari A, Miossec P. Immature muscle precursors are a source of interferon-beta in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum 2012, 64:533-541.
47. Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A. Arthritis Rheum 2009, 60:2505-2512. 10.1002/art.24689, 19644888.
48. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901. 10.1016/S0092-8674(00)80801-6, 10399917.